Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Ticinesi, Andreaa; b; c; * | Mancabelli, Leonardod | Carnevali, Lucad | Nouvenne, Antonioa; b; c | Meschi, Tizianaa; b; c | Del Rio, Danielea; e | Ventura, Marcoa; d | Sgoifo, Andreaa; d | Angelino, Donatof
Affiliations: [a] Microbiome Research Hub, University of Parma, Parma, Italy | [b] Department of Medicine and Surgery, University of Parma, Parma, Italy | [c] Geriatric-Rehabilitation Department, Parma University-Hospital, Parma, Italy | [d] Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy | [e] Department of Food and Drugs, University of Parma, Parma, Italy | [f] Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy
Correspondence: [*] Correspondence to: Dr. Andrea Ticinesi, MD, PhD, Microbiome Research Hub and Department of Medicine and Surgery, University of Parma, Geriatric-Rehabilitation Department, Azienda Ospedaliero-Universitaria di Parma, Via Antonio Gramsci 14, 43126 Parma, Italy. Tel.: +39 0521 703871; Fax: +39 0521702383; E-mails: [email protected]; [email protected]; ORCID-ID: 0000-0001-9171-8592
Abstract: Animal studies increasingly indicate that the gut microbiota composition and function can be involved in the pathophysiology and progression of Alzheimer’s disease (AD) at multiple levels. However, few studies have investigated this putative gut-brain axis in human beings, and none of them considered diet as a determinant of intestinal microbiota composition. Epidemiological studies highlight that a high intake of fruit and vegetables, such as that typical of the Mediterranean diet, can modulate AD progression. Thus, nutritional interventions are being increasingly studied as a possible non-pharmacological strategy to slow down the progression of AD. In particular, polyphenols and fibers represent the nutritional compounds with the higher potential of counterbalancing the pathophysiological mechanisms of dementia due to their antioxidant, anti-inflammatory, and anti-apoptotic properties. These actions are mediated by the gut microbiota, that can transform polyphenols and fibers into biologically active compounds including, among others, phenyl-γ-valerolactones, urolithins, butyrate, and other short-chain fatty acids. In this review, the complex mechanisms linking nutrition, gut microbiota composition, and pathophysiology of cognitive decline in AD are discussed, with a particular focus on the role of polyphenols and fibers. The gaps between pre-clinical and clinical studies are particularly emphasized, as well as the urgent need for studies comprehensively evaluating the link between nutrition, microbiome, and clinical aspects of AD.
Keywords: Aging, butyrate, cognitive impairment, short-chain fatty acids
DOI: 10.3233/JAD-215493
Journal: Journal of Alzheimer's Disease, vol. 86, no. 3, pp. 961-982, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]